Serum-based glycoproteins demonstrate success in predicting immune checkpoint inhibitor therapy outcomes.
Breakthroughs in immunotherapy: glycoproteins as predictive biomarkers for therapeutic response
Posted in innovation
Posted in innovation
Serum-based glycoproteins demonstrate success in predicting immune checkpoint inhibitor therapy outcomes.